NasdaqGS - Delayed Quote USD

Praxis Precision Medicines, Inc. (PRAX)

46.89 +0.30 (+0.64%)
At close: April 19 at 4:00 PM EDT
45.98 -0.91 (-1.94%)
After hours: April 19 at 4:54 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,447.00
2,447.00
--
--
--
Operating Expense
128,820.00
128,820.00
214,986.00
167,332.00
61,968.00
Operating Income
-126,373.00
-126,373.00
-214,986.00
-167,332.00
-61,968.00
Net Non Operating Interest Income Expense
--
--
--
--
140.00
Other Income Expense
3,096.00
3,096.00
957.00
271.00
140.00
Pretax Income
-123,277.00
-123,277.00
-214,029.00
-167,061.00
-61,828.00
Tax Provision
--
--
--
--
-8.00
Net Income Common Stockholders
-123,277.00
-123,277.00
-214,029.00
-167,061.00
-70,323.00
Diluted NI Available to Com Stockholders
-123,277.00
-123,277.00
-214,029.00
-167,061.00
-70,323.00
Basic EPS
-18.69
--
-69.65
-59.10
-117.90
Diluted EPS
-18.69
--
-69.65
-59.10
-117.90
Basic Average Shares
6,594.32
--
3,073.10
2,830.27
596.68
Diluted Average Shares
6,594.32
--
3,073.10
2,830.27
596.68
Total Operating Income as Reported
-126,373.00
-126,373.00
-214,986.00
-167,332.00
-61,968.00
Total Expenses
128,820.00
128,820.00
214,986.00
167,332.00
61,968.00
Net Income from Continuing & Discontinued Operation
-123,277.00
-123,277.00
-214,029.00
-167,061.00
-61,820.00
Normalized Income
-123,277.00
-123,277.00
-214,029.00
-167,061.00
-61,820.00
Interest Income
--
--
--
--
140.00
Net Interest Income
--
--
--
--
140.00
EBIT
-126,373.00
-126,373.00
-214,986.00
-167,332.00
-61,968.00
EBITDA
-125,941.00
-125,941.00
-214,567.00
-167,150.00
-61,918.00
Reconciled Depreciation
432.00
432.00
419.00
182.00
50.00
Net Income from Continuing Operation Net Minority Interest
-123,277.00
-123,277.00
-214,029.00
-167,061.00
-61,820.00
Normalized EBITDA
-125,941.00
-125,941.00
-214,567.00
-167,150.00
-61,918.00
Tax Rate for Calcs
--
--
--
--
0.00
12/31/2020 - 10/16/2020
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

NMRA Neumora Therapeutics, Inc.
10.18
-3.51%
 
PTGX Protagonist Therapeutics, Inc.
25.61
+1.55%
 
MLTX MoonLake Immunotherapeutics
42.19
-0.14%
 
CGEM Cullinan Therapeutics, Inc.
15.66
-13.29%
 
PCVX Vaxcyte, Inc.
60.83
+0.35%
 
IMVT Immunovant, Inc.
28.22
-0.35%
 
TSHA Taysha Gene Therapies, Inc.
2.2700
-5.81%
 
EWTX Edgewise Therapeutics, Inc.
15.23
-1.42%
 
NRIX Nurix Therapeutics, Inc.
13.59
-5.89%
 
LBPH Longboard Pharmaceuticals, Inc.
17.44
-3.16%